Anju Nair is an Oncology physician affiliated with Lexicon Pharmaceuticals. OpenAlex indexes 35 publications with 629 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3500 Gaston Ave
Dallas, TX 75246
Telephone
214-820-2233Provider last certified this registry record 2 Dec 2022.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20258 payments
- Geron CorporationProgram year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
51.1%Other antiemetics44.2%Fosaprepitant100%Part B, office-administered≥16 patientsSerotonin-3 Receptor Antagonist6%Palonosetron hcl52%Granisetron hydrochloride45%Ondansetron Hcl3%Part D + Part B<11 patients+ 1 more class in this area
Cancer & immunology
39.9%Microtubule Inhibitor36.3%Paclitaxel100%Part B, office-administered≥13 patientsAromatase Inhibitor1.5%Anastrozole88%Letrozole12%Part D<11 patients+ 6 more classes in this area
Sensory organs
6.9%Corticosteroid6.9%Dexamethasone sodium phosphate98%Dexamethasone2%Part D + Part B<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”